Ayana Jordan, MD, PhD, Project/Medical Director
Dr. Jordan completed an MD, PhD program at Albert Einstein College of Medicine of Yeshiva University. She completed a general adult psychiatric residency and addiction psychiatry fellowship at Yale University, where she served as Program-Wide Chief. Currently, Dr. Jordan is an assistant professor at Yale and a physician attending at Connecticut Mental Health Center. She is committed to increasing access to addiction services within minority communities, both nationally and abroad. Dr. Jordan has done research in Sierra Leone, West Africa examining the link between, mental illness, substance use and stigma, and has served as an expert witness discussing these issues. In Connecticut, Dr. Jordan is working with Black churches to offer evidenced based interventions for substance use. Dr. Jordan is the proud recipient of various clinical and research awards and was recently inducted into the Top 40 under 40 Society by her undergraduate alma mater.
Jeanette M. Tetrault, MD, FACP, FASAM, Assistant Medical Director
Dr. Tetrault is an Associate Professor of Medicine in the Section of General Internal Medicine at Yale School of Medicine. She is the founding Program Director for the Yale’s Addiction Medicine Fellowship. She is a primary care physician and addiction medicine specialist at the APT Foundation, where she provides primary care services, chronic disease management, including HIV and Hepatitis C treatment; and addiction specialty care including methadone, buprenorphine and naltrexone treatment. She co-directs the Addiction Recovery Clinic, a specialty clinic embedded within the residency continuity practice, which serves a dual clinical and educational mission. She is on the Board of Directors of the Addiction Medicine Foundation and the Addiction Medicine Fellowship Director’s Association. She is co-chair of the Society of General Internal Medicine’s (SGIM) Alcohol, Tobacco and Other Drug Use Interest Group, and past- president for the New England Region of SGIM. Her academic interest focuses on improving care of patients with substance use and the chronic diseases associated with addiction. She is recognized as a Macy Foundation Faculty Scholar for her work expanding addiction medicine curricula for health professions students at Yale. Dr. Tetrault has published widely in the field of Addiction Medicine including epidemiologic investigation, investigation of unique delivery care models, examination of safety of addiction pharmocotherapies, and addiction medicine curriculum design, evaluation, and dissemination.
Kathryn Cates-Wessel, PI
Ms. Cates-Wessel has more than 30 years of background and experience in the substance use disorder field in administration, medical education, and policy. She is Chief Executive Officer of the American Academy of Addiction Psychiatry (AAAP) and Principal Investigator and Project Director for both the PCSS and STR-TA grant. As Principal Investigator and Project Director of these projects, she oversees the overall administration of the projects staff; consultants and sub-awards; negotiating contracts and overseeing work of partner organizations, consultants and vendors; and ensuring that all aspects of this these projects are undertaken according to the project plans. Prior to her work at AAAP, she was Associate Director of Brown University's Center for Alcohol and Addiction Studies for over 19 years and Executive Director of Physicians and Lawyers for National Drug Policy, a think tank of leaders from law and medicine advocating for prevention/treatment of addicts over incarceration. Prior to that she was Associate Director of a residential treatment center for adolescents for substance use disorders and co-occurring mental disorders.
Katie Clark, MSPH, CADC, Project Evaluator
Ms Clark is a Research Consultant at Clark Health Education and Research Solutions, LLC. She provides research consultation services to academic institution, hospitals, non-profit community-based organizations, and state and local governments. Katie specializes in research design and program evaluation that uses both quantitative and qualitative approaches. She is a doctoral student in Translational Health Sciences at George Washington University and her dissertation topic is focused on successful buprenorphine/naloxone implementation in Connecticut. Katie earned her Master of Science in Public Health and a Certificate in Survey Methodology from UNC Chapel Hill. She completed her undergraduate studies at Godard College with a focus on pregnancy and substance use, public health and audio journalism.
Joy Ortiz, Interim Program Manager
Educated in the field of Business Administration, at Quinnipiac University in Hamden, Connecticut, and a Graduate of The Greater New Haven Leadership Program, Joy Ortiz has been a part of the Yale University Management and Professional Staff for over 20 years. She currently holds the position of an Administrative Associate/Program Coordinator for the Addiction Psychiatry Fellowship Program, an ACGME Accredited Program and is also involved with the National Institute of Drug Abuse Research Fellowship Program. Joy Ortiz assist in the recruiting of Fellows for both programs. For the National Institute of Drug Abuse Program, Joy works directly with the Program Director initiating and monitoring the annual budget, the annual research reporting, and all other training activities required by the Sponsoring institution. For the Addiction Psychiatry Fellowship Program, Joy Ortiz manages the recruiting and activities of the one-year Fellowship Program.
Joy Ortiz is very active in the New Haven Community, volunteering for Habitat for Humanity, Youth mentorship, teenage counselling and provided soft skills training to high school students through the New Haven School System. Ms. Ortiz also served on the Executive Board of the Greater New Haven Exchange Club, a National Organization that focuses on Community Service, Americanism and the Prevention of Child Abuse.
REACH Advisory Board
The Advisory Board, with members recruited outside of Yale, consists of a diverse panel of experts (experts from various disciplines and community members), with collective international and national experience in both addiction education and reducing behavioral health disparities among racial and ethnic minority populations. Through these partnerships, the REACH program creates a support network specifically designed to increase capacity of culturally-informed physicians, while also increasing the recruitment of trainees from URM backgrounds, who are able to meet the unique needs of URM PWSUD.
Dr Adger is Professor of Pediatrics at the Johns Hopkins University School of Medicine and Director of Adolescent Medicine at the Johns Hopkins Hospital. He has served as Director of the Substance Abuse Assessment/Intervention Team at The Johns Hopkins Hospital Adolescent Program and previously served as Director of The Johns Hopkins Substance Abuse Faculty Development Program. A major focus of Dr. Adger’s research and professional interests has been in the area of substance abuse education for health professionals. He has become nationally recognized for his work in developing substance abuse curricula and clinical practice standards for health professionals. In 1997-98 he served as Deputy Director of the White House Office of National Drug Control Policy and is previous Co-Director of the Strategic Planning Initiative funded by HRSA to advise the federal government and others on improving and expanding interdisciplinary education and training of health professionals in substance use disorders. He is currently PI and Project Director of the HRSA funded Leadership Education in Adolescent Health project at the Johns Hopkins Hospital and Faculty Leader of the Florence Sabin College in the Johns Hopkins School of Medicine. He is a Diplomate of and serves as the Pediatric Discipline Director for the American Board of Addiction Medicine Foundation.
Adina E. Bowe, MD
Adina E. Bowe is currently an Assistant Professor in Internal Medicine and Psychiatry at West Virginia University Charleston Division. She is board certified in Internal Medicine, Psychiatry and Addiction Psychiatry. Her special interests reside in treating medically complexed, dually diagnosed individuals with addiction disorders in rural communities. She is an advocate for the integrated care model of health delivery. Dr. Bowe is an active member of American Academy of Addiction Psychiatry, the American Medical Association and the American Psychiatric Association. In her spare time she enjoys visiting her family in the Bahamas, hiking and kayaking.
Andrew Danzo is Director of Fellowship Development for The Addiction Medicine Foundation (TAMF). He has been involved in developing fellowship training programs since 2010 as part of the successful effort to build a graduate medical education infrastructure for Addiction Medicne and achieve its formal recognition by the American Board of Medical Specialties and the Accreditation Council for Graduate Medical Education. Based in the Department of Family Medicine at the University at Buffalo Jacob School of Medicine and Biomedical Sciences, Mr. Danzo has also worked on a variety of projects, including faculty development the New York State Rural Health Research Center and New York State Area Health Education Center. From 2000-2009, he served as Associate Editor of the Journal of Rural Health, the premiere peer-reviewed publication focused on healthcare access and related issues for the nation’s nonmetropolitan population. He earned a BA in economics and political science from Rutgers University and previously worked for a number of years as a journalist.
Patrick Dowling, MD, MPH
Dr. Patrick Dowling is Kaiser Endowed Professor of Community Medicine and Chair of the UCLA Department of Family Medicine (UDFM). A graduate of the Medical College of Ohio, he completed his residency training in Family Medicine at Cook County Hospital in Chicago and earned an MPH at Michigan. He is board certified in Family Medicine, Preventive Medicine/Public Health. The UDFM sponsors a Family Medicine residency as well as fellowships in Sports Medicine and Addiction Medicine. Further, UDFM operates a large NIH- funded program in partnership with universities in S. Africa and Vietnam to address substance abuse and HIV, and is assisting the health ministry of Mozambique in developing Family Medicine.
After completing training in Chicago, he served as medical director at migrant health centers for three years with Cesar Chavez on the rural Mexican-Californian border. He then returned to Cook County Hospital and for seven years, served as Associate Chair of Family Medicine, followed by three years as Program Director at Brown University. Prior to joining UCLA as chair of the UDFM in 1998, he served as Chair of Family Medicine at Harbor-UCLA for nine years.
His professional interests include health policy, the provision of care to under-resourced communities and the linkage of graduate medical education to underserved communities as a means to improve access and reduce health outcomes disparities. Moreover, his research interests include cross cultural and bi-national medicine and the integration of behavioral medicine and substance abuse treatment within primary care.
CDR Karen Hearod is a Licensed Clinical Social Worker and a member of the Choctaw Nation of Oklahoma. Prior to accepting her new role as Regional Administrator, CDR Hearod served as the Indian Health Service Oklahoma City Area Acting Behavioral Health Consultant. In this position CDR Hearod had oversight over behavioral health and substance abuse programs across Oklahoma, Texas, and Kansas providing services impacting 410,00 Native Americans. In addition to providing leadership as Chair for the IHS National Zero Suicide Advisory Committee, she served as a member of the National Suicide Crisis Policy Committee working to establish the first IHS national suicide care policy.
During her federal career, CDR Hearod has served as the Chief Behavioral Health Officer for the Choctaw Nation of Oklahoma. In this role, Hearod oversaw a behavioral health system which spanned the area equivalent to the size of Vermont including 13 facilities and 90 staff. She was successful in seeking out and implementing multiple grants addressing substance abuse and suicide prevention, sexual assault forensic treatment and prevention, HIV and teen pregnancy prevention, and cardiovascular disease prevention. She led the creation of the Choctaw Nation Wind Horse Treatment Center providing family centered substance abuse prevention and treatment services for high risk families in an area with little access to care. She also facilitated the transition to a fully integrated Electronic Health Record for Behavioral Health with Choctaw Nation Health programs greatly improving continuity of care.
Kevin Kunz, MD, MPH, DFASAM
Since 2013, Dr. Kunz has been the Executive Vice President of the American Board of Addiction Medicine (ABAM) and The American College of Academic Addiction Medicine (ACAAM, formerly the Addiction Medicine Foundation) and previously served as President of both. He is a graduate of the University of Hawaii’s John A. Burns School of Medicine, and serves now on that clinical faculty. Dr. Kunz has practiced primary care and Addiction Medicine in Hawaii for 40 years. Under his executive leadership at ABAM and ACAAM over 4,000 physicians have received national certification in Addiction Medicine. The field of Addiction Medicine gained recognition by the ABMS and the ACGME, resulting in 62 one-year Addiction Medicine Fellowships being established and accredited. Dr. Kunz has authored or co-authored multiple journal articles in the field of Addiction Medicine, and is a Section Editor for the field’s primary text, “Principles of Addiction Medicine”. In the recently published 6th Edition of this text, he authored a chapter entitled “The Addiction Medicine Physician as a Change Agent for Prevention and Public Health”. Dr. Kunz has had a career interest in issues of interdisciplinary care and the provision of equitable care to underserved populations. Since 2014, he has been the PI on a $3.5 Million Addiction Medicine workforce development grants from philanthropic and governmental sources.
Dr. Kunz has received recognition for his local, state and national work in addiction prevention and treatment. He has been a recipient of: the AMERSA John P. McGovern Award for Excellence in Medical Education; Clinician of the Year Award from the Hawaii Medical Association; Outstanding Service Award- Hawaii Island Rural Health Association; the Governor’s Kilohana Award for Outstanding Volunteerism; and the Annual Award of the American Society of Addiction Medicine among others. Dr. Kunz is focused on expanding the Addiction Medicine physician workforce and the development of fellowship training programs for the purpose of bringing evidence informed prevention and treatment to patients, families and health care systems.
Paula J. Lum, MD MPH is Professor of Clinical Medicine and Program Director of the UCSF Primary Care Addiction Medicine Fellowship. She has been a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at San Francisco General Hospital since 1999. Board certified in internal medicine and addiction medicine, Dr. Lum practices at the place where HIV, addiction, and poverty collide. Her research and clinical activities are grounded in evidence-based, patient-centered care to improve health outcomes and life quality of the urban poor. Her current areas of focus include: (1) HIV and viral hepatitis prevention and treatment in persons who inject drugs, (2) evidence-based interventions in primary care and non-traditional settings for substance use disorders and their complications, and (3) curricular interventions to provide health care professionals with the skills, knowledge, and confidence to offer effective patient-centered care to persons who use drugs.
Ismene Petrakis, MD
Dr. Ismene Petrakis is Professor of Psychiatry at the Yale University School of Medicine and the Chief of Psychiatry and Mental Health Services at VA Connecticut Healthcare System. She is also the Director of the Addiction Psychiatry Residency at Yale University School of Medicine, the principal investigator of a National Institute of Drug Abuse (NIDA-T32) training grant. She is involved in the education of medical students and residents at many stages of their training, particularly around clinical issues of addictive disorders. She is also a grant funded investigator (funding sources over the years have included NIH, VA, Department of Defense, NARSAD and the Stanley Foundation) whose research interests include developing an understanding of the neurobiology of alcohol dependence and in testing potentially effective treatments for individuals with alcohol dependence and comorbid Axis I psychiatric disorders.
Dr. Petrakis received her undergraduate degree at Northwestern University and her medical training at the University of Pittsburgh, School of Medicine. She completed her residency training at Yale University School of Medicine and then completed an Addiction Psychiatry Fellowship, also at Yale University. Since completing her training, Dr. Petrakis has over 20 years of experience in the clinical treatment of addictive disorders, research in this field and in the education of residents, medical students, post-doctoral fellows and other mental health trainees in the assessment, accurate diagnosis and treatment of patients with addictive disorders.
Richard Schottenfeld, Professor and Chair of the Department of Psychiatry and Behavioral Sciences at Howard University College of Medicine: A leading clinical researcher, educator, and developer of clinical programs and services, Dr. Schottenfeld has played a key role in development and expansion of primary care-based treatments for opioid use disorder in the U.S. and internationally. He has directed training programs in Addiction Psychiatry and drug abuse clinical research and an interdisciplinary faculty development program for faculty in Internal Medicine, Obstetrics and Gynecology, Pediatrics, and Psychiatry who have subsequently played major roles in developing drug abuse clinical research and training programs.
Olapeju Simoyan, MD, MPH, BDS, FAAFP
Dr Simoyan is the program director for the addiction medicine fellowship at Geisinger Marworth Treatment Center in Waverly, Pennsylvania. She is also an associate professor of Family Medicine and Epidemiology at the Geisinger Commonwealth School of Medicine in Scranton PA and serves on the American Board of Preventive Medicine’s sub-committee on addiction medicine. Dr Simoyan earned a dental degree from the University of Ibadan in Nigeria, a Master of Public Health degree from the Johns Hopkins University Bloomberg School of Public Health and a medical degree from Penn State University College of Medicine in Hershey, PA. She completed an internship in psychiatry/family medicine at the University of Pittsburgh Medical Center/Western Psychiatric Institute and completed her family medicine residency at the Penn State/Good Samaritan Hospital Family and Community Medicine Residency program. Dr Simoyan is board certified in addiction medicine, family medicine and dental public health. She has contributed to international public health education as a Fulbright specialist in Nigeria and an Erasmus Mundus scholar in France and the U.K. She has also volunteered on medical mission projects in Nigeria and Haiti with humanitarian organizations including Pro - Health International and FaithCare, Inc.
Dr Simoyan’s numerous scholarships and awards include the Emerging Leader award from the Family Medicine Education Consortium (2010) and the American Association of Medical College’s Herbert Nickens Faculty Fellowship (2012). She was recognized by the Northeastern Pennsylvania Business Journal as one of the Top 25 Women in Business in 2015 and she was a second prize winner in the State Department’s Citizen Diplomacy Challenge in the same year.
In her spare time, she enjoys spending time with family and friends, travel, writing, photography and playing various musical instruments.
Anika Alvanzo, MD, MS, FASAM, FACP
Anika Alvanzo, MD, MS, FASAM, FACP is an Assistant Professor in the Division of General Internal Medicine at Johns Hopkins University School of Medicine. Dr. Alvanzo is a graduate of the George Washington University School of Medicine and Health Sciences and holds a master’s degree in biostatistics from Virginia Commonwealth University. She is board certified in Internal Medicine and is a Diplomate of the American Board of Addiction Medicine. Dr Alvanzo is a Fellow of ASAM, the Region V Director for the ASAM Board of Directors and the Immediate Past President of the Maryland-DC Society of Addiction Medicine (MDDCSAM).
At Johns Hopkins, Dr. Alvanzo is currently the Associate Medical Director at Addiction Treatment Services and the Center for Addiction and Pregnancy where she oversees the medical care of patients in these two comprehensive, outpatient substance use disorder treatment programs. Dr. Alvanzo is also the Director of the Addiction Medicine Rotation for the Johns Hopkins Medicine-Pediatrics Urban Health and Urban Health Primary Care Internal Medicine Residency track programs. Her research interests include gender and race/ethnicity differences in the risk for substance use disorders and the association between psychological trauma, posttraumatic stress, and substance use, particularly in women. Dr. Alvanzo has served as an expert on National Institutes of Health (NIH) and Substance Abuse and Mental Health Services Administration (SAMHSA) panels on the role of opioids in chronic pain and integration of recovery-oriented care in hospital and medical settings, respectively. Most recently Dr. Alvanzo was an invited rapporteur and panelist at the National Academies of Sciences, Engineering and Medicine, “Workshop on Integrating Infectious Disease Considerations with Response to the Opioid Epidemic”.
Bachaar Arnaout, MD
Bachaar Arnaout, MD, is Assistant Professor of Psychiatry at the Yale School of Medicine, and serves as Director of the Detoxification and Addiction Stabilization Service and Medical Director of the Psychosocial Residential Rehabilitation Treatment Program at VA Connecticut Healthcare System. After graduating from the Jagiellonian University in Kraków, Poland, Dr. Arnaout trained in psychiatry at St. Luke’s-Roosevelt Hospital Center in New York, where he also completed the Intensive Psychoanalytic Psychotherapy Program at the William Alanson White Institute of Psychiatry, Psychoanalysis & Psychology. He then trained in addiction psychiatry at the Yale School of Medicine. Dr. Arnaout holds board certification in psychiatry, addiction psychiatry, addiction medicine, hospice and palliative medicine, and brain injury medicine. His academic interests include the psychotherapy and psychopharmacology of addiction and co-occurring disorders, and medical education.
Nedson Campbell, MD
Dr. Campbell grew up in the Philadelphia suburbs. He went to Temple University to study psychology and later biology where he fostered an interest in attending medical school. After graduating from college he worked as a drug and alcohol counselor for a year before he was accepted into Temple University School of Medicine. After medical school he went to Yale for a psychiatric residency and later a fellowship in addictions. After graduation he worked as an addictions medical director at a small community hospital in the Hartford, CT, and presently he works as the medical director of a private behavioral company in Philadelphia. In his spare time, he enjoys traveling, jiujitsu, and long walks in the park with his dog.
Hector Colon-Rivera, MD
Dr. Colon-Rivera grew up between San Juan and Vieques, Puerto Rico. Following medical school in Puerto Rico and a residency in psychiatry at the Boston University Medical Center, he completed his addiction psychiatry training at Yale University. He is currently a faculty member at the University of Pennsylvania and the Philadelphia Veteran Affairs Medical Center where he specializes in the acute care of patients with a wide variety of mental health and substance use disorders. Alongside he is an attending physician at the University of Pittsburg Medical Center working on an emerging community program to increase rural access to Medical Assisted Treatments for patients with substance use disorder.
He has been committed to actively serving the American Psychiatric Association (APA) in leadership positions. He served at the Joint Reference Committee, the Board of Trustee, and the APA Council on Addiction Psychiatry. He is currently the president of the Hispanic Caucus and a consultant for the Council on Membership for the APA.
Dr. Colon-Rivera also serves as a clinical advisor for the Advisory on Alcohol and Other Drugs committee for the State of Pennsylvania, and he is the senior advisor for the Opioid State Targeted Response Technical Assistance for Puerto Rico.
E. Jennifer Edelman, MD, MHS
Dr. Edelman is an Associate Professor at the Yale School of Medicine. Certified as an internist, HIV specialist and in Addiction Medicine, she serves as the physician consultant for the Addiction Treatment Program at the Yale-New Haven Hospital Nathan Smith HIV clinic. Over the past 10 years, her work has focused on addressing opioid and alcohol use to promote HIV prevention and treatment. This includes leading NIH-funded studies focused on understanding harms associated with opioid use among patients living with HIV and efforts to promote implementation of addiction treatment in clinical settings. She is Associate Director of the Research in Addiction Medicine Scholars (RAMS) Program. She has a BS from Cornell University, MD from Columbia University and MHS from Yale University.
Ellen Edens, MD, MPE, MA
Dr. Edens is an Assistant Professor of Psychiatry at Yale University School of Medicine. In 2002, Dr. Edens received her MD from the Johns Hopkins School of Medicine and completed psychiatry residency training and graduate work in psychiatric epidemiology at Washington University in St. Louis. She is board-certified in addiction psychiatry following advanced training in Addiction Psychiatry at Yale University School of Medicine, where she joined the faculty in 2011. Dr. Edens is the Associate Director of the Addiction Psychiatry Residency at Yale, an ACGME-accredited program, overseeing the program’s didactic curriculum and clinical supervision. She serves as co-director of the VA Interprofessional Advanced Fellowship in Addiction Treatment. Her clinical and research interests dovetail in the areas of co-occurring addiction and chronic pain and expansion of access to evidence-based treatments for addiction, particularly opioid and alcohol use disorders. She is the clinical co-director of the VA Opioid Reassessment Clinic, a clinic designed to assess the safety, efficacy, and misuse of opioids by Veterans treated with prescription opioids for chronic pain. Additionally, she is actively working on developing and disseminating interprofessional educational material on the topic of addiction screening, diagnosis, and initiation of substance use treatment.
David A. Fiellin, MD
David A. Fiellin, MD, is a Professor of Medicine, Emergency Medicine and Public Health at Yale. He Directs the Yale Program in Addiction Medicine and the Clinical and Health Services Research Core at Yale’s Center for Interdisciplinary Research on AIDS. He is board certified in Internal Medicine and Addiction Medicine. His NIH-funded research is on the interface between substance use and general medical settings including office-based practice, primary care, Emergency Department and HIV specialty settings. He has received awards from the American Association for the Treatment of Opioid Dependence, the American Society of Addiction Medicine, AMERSA, and the Hazelden Betty Ford Foundation. He is Co-Editor of the ASAM textbook, Principles of Addiction Medicine, 4th, 5th and 6th Editions, and on the Editorial Boards of 4 addiction specialty journals. He has served on the Board of Directors of the College on Problems of Drug Dependence and as Co-Chair of the Substance Abuse Interest Group at the Society of General Internal Medicine.
Lamia Haque, MD, MPH
Lamia Haque completed her medical training at the Alpert Medical School of Brown University and a masters in public health at the Mailman School of Public Health at Columbia University. She completed her internal medicine training in the Yale Primary Care Residency Program followed by the Yale Addiction Medicine Fellowship. She is now a fellow in the Yale Digestive Diseases Section with a scholarly focus on epidemiology and treatment of substance use disorders in patients with chronic hepatitis C infection and cirrhosis.
Brady Heward, MD
Brady Heward, MD, attended medical school at Yale University School of Medicine. After completing medical school, he participated in a general psychiatry internship and residency at Yale. During residency he took advantage of the diverse clinical opportunities working at a community mental health center, a private hospital and at the VA. In addition he spent time researching how culture can impact parental behaviors and definitions of childhood maltreatment. Following residency, Dr. Heward participated in a public psychiatry fellowship at Yale working at the Connecticut Mental Health Center primarily working on the inpatient unit. He subsequently left Connecticut to complete a child and adolescent fellowship in Vermont. Dr. Heward is currently back at Yale completing an addiction fellowship and hopes to further work with diverse and underserved adolescents and young adults with co-occurring disorders.
Stephen R. Holt, MD, MS, FACP
Dr. Holt attended Columbia University’s College of Physicians & Surgeons, and subsequently completed his residency and Chief Residency at Yale School of Medicine’s Primary Care Internal Medicine Residency Program before joining the faculty. He has served as the Associate Program Director of Yale’s Primary Care Program since 2010. His areas of interest include addiction medicine, medical education, and the art and science of physical diagnosis. He is board-certified in both Internal Medicine and Addiction Medicine.
Current clinical activities include ambulatory clinic precepting, co-directing Yale’s Addiction Recovery Clinic, and general medicine ward attending several months per year. He is the director of Musculoskeletal Education and Addiction Medicine Education within the Primary Care training program, and codirects the Clinician Educator Distinction Track within the Department of Medicine. He has won numerous teaching awards at Yale and nationally, including the Faculty Teacher of the Year Award (Yale Primary Care Residency, 2009 and 2017), the Leonard Tow Humanism in Medicine Award (Yale School of Medicine, 2014), and the New Investigator/Educator Award (Association for Medical Education and Research in Substance Abuse,2016) and gives recurring lectures on physical diagnosis, medical education, and addiction medicine topics both at Yale and nationally. Dr. Holt has authored numerous articles, reviews, and book chapters on addiction medicine topics and is a premier author for Yale’s Office-based Medicine Curriculum, used by over 200 residency programs nationally.
Outside of the hospital, Dr. Holt is an avid guitarist and naturalist who genuinely enjoys the art and science of tree identification. He lives in Connecticut with his wife and their two daughters (9 and 10 years old) that entertain him nightly.”
Theddeus Iheanacho, MD
Dr. Theddeus Iheanacho, MD, is an Assistant Professor of Psychiatry at Yale University School of Medicine and the Medical Director of Errera Community Care Center, VA Connecticut Healthcare System. He is board certified in general psychiatry and addiction psychiatry. In addition to teaching and clinical work, he has research interest in substance use disorders, specifically, increasing access to and reducing barriers to the utilization of medication assisted treatment for substance use disorders in the homeless population. Dr. Iheanacho completed medical school in Nigeria and psychiatric training in Dublin, Ireland and the United States.
Anna Lembke, MD
Anna Lembke, MD, is an associate professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She is medical director of Stanford Addiction Medicine, program director for the Stanford Addiction Medicine Fellowship, and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. Dr. Lembke received her BA in Humanities from Yale University and her MD from Stanford University, where she also completed her residency in Psychiatry and fellowship in mood disorders. She is a diplomate of the American Board of Psychiatry and Neurology, and of the American Board of Addiction Medicine. Dr. Lembke has developed multiple teaching programs on drug misuse and addiction therapy. She has held multiple leadership and mentorship positions and received the Stanford’s Chairman’s Award for Clinical Innovation, and the Stanford Departmental Award for Outstanding Teaching. She chaired the Planning Committee for the California Society of Addiction Medicine (CSAM) Annual Addiction Medicine Conference and was the president of the Addiction Medicine Fellowship Directors Association (AMFDA). She is the author of the bestselling book, “Drug Dealer, MD: How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop” (Johns Hopkins University Press, November 2016).
Carla Marienfeld, MD
Carla Marienfeld, MD, is a board-certified addiction psychiatrist at the University of California, San Diego who supports recovery in a harm-reduction approach through therapy, motivational interviewing, and medication treatment. An associate clinical professor of psychiatry, her research looks at health outcomes for individuals with substance use disorders, and she published a book Motivational Interviewing for Clinical Practice. She has been highly involved in education of colleagues and trainees about addiction psychiatry and effective interventions including buprenorphine treatment and motivational interviewing, and she is the fellowship director for the UCSD Addiction Psychiatry Fellowship. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale. During her residency, she was chief resident of psychiatry and founded (and later led) the Yale Global Mental Health Program as junior faculty at Yale. She earned a medical degree with honors from Baylor College of Medicine in Houston.
Kenneth Morford, MD
Dr. Morford is an Addiction Medicine Fellow and Postdoctoral Associate at Yale School of Medicine. He completed his residency in the Yale Primary Care Internal Medicine Program and served as Chief Resident for the VA Connecticut Healthcare System Center of Excellence in Primary Care Education. He currently provides primary care and addiction treatment services at the APT Foundation, which is a large, non-profit addiction recovery center focused on open access and harm reduction. He is a scholar in the Research in Addiction Medicine Scholars (RAMS) Program funded by the National Institute on Drug Abuse (NIDA) and studies the effects of benzodiazepine use in patients with opioid use disorder. He also works on two studies focused on integrating addiction treatment in HIV clinics. He is a clinical coach for medical and nurse practitioner students, faculty advisor for the Yale Addiction Medicine Collaborative, and teaches workshops related to addiction, chronic pain, motivational interviewing, and primary care.
Srinivas Muvvala, MD, MPH
Dr. Muvvala is an assistant professor of psychiatry at the Yale School of Medicine and the medical director of the Substance Abuse Treatment Unit (SATU) at the Connecticut Mental Health Center (CMHC). He oversees the clinical and research programs at SATU and is involved in medical student, residency and fellowship education. His clinical and research interests are in investigating and disseminating optimal pharmacotherapies for the treatment of opioid, tobacco and alcohol use disorders and in providing comprehensive treatment for individuals with comorbid addictive and psychiatric disorders.
Patrick G. O'Connor, MD, MPH, FACP
Dr. Patrick O'Connor is a Dan Adams and Amanda Adams Professor of General Medicine and Chief of General Internal Medicine at Yale University School of Medicine and Yale New Haven Hospital in New Haven, Connecticut. Dr. O'Connor came to Yale as a fellow in the Robert Wood Johnson Clinical Scholars Program during which time he also received a M.P.H. from the Yale School of Public Health. As Chief of General Internal Medicine at Yale he led several new initiatives in patient care, education, and research and has overseen a 3-fold expansion in the size of the faculty and 10-fold increase in research funding. Dr. O'Connor's research has focused on the interface between primary care and addiction medicine. Specific topics within his research area have included: 1) the integration of primary care and substance use disorder treatment services, 2) strategies for primary care-based opioid detoxification and opioid maintenance for the treatment of opioid use disorder, 3) strategies for managing unhealthy alcohol use and alcohol use disorder in primary care settings, 4) medical education about addiction, and 5) addiction health policy. He served as an author on Facing Addiction in America. The Surgeon General’s Report on Alcohol, Drugs, and Health. He has also collaborated with federal agencies such as The White House Office on Drug Control Policy and with addiction-focused organizations in academia and the private sector. Dr. O'Connor is Past President of the American Board of Addiction Medicine (ABAM) and the Addiction Medicine Foundation (TAMF), Past President of the Association for Medical Research and Education in Substance Abuse (AMERSA) and is a member of the new Addiction Medicine Sub-board and Examination Committee for the American Board of Preventive Medicine. As Chief of the Section of General Internal Medicine at Yale he was recognized with his receipt of the first annual Chief's Recognition Award from the Society of General Internal Medicine (SGIM) and the Association of Chiefs of General Internal Medicine (ACGIM). He received both the Mentorship and the McGovern Award from AMERSA.
Alexander Y. Walley, MD, MSc
Dr. Walley is an Associate Professor of Medicine at Boston University School of Medicine and a general internist and addiction medicine specialist at Boston Medical Center. He has been the director of the Boston Medical Center Addiction Medicine Fellowship program since 2011. His research focus is on the medical complications of substance use, specifically HIV and overdose. He provides primary care and office-based addiction treatment for patients with HIV at Boston Medical Center and on the inpatient Addiction Consult Service, which he founded in 2015. He is the medical director for the Massachusetts Department of Public Health’s Opioid Overdose Prevention Pilot Program. Since 2007, the MDPH program has trained over 80,000 people in Massachusetts’s communities, including people who use opioids, people in recovery, and their social networks. He graduated from Harvard College, received his MD from Johns Hopkins School of Medicine and Masters of Science in epidemiology from Boston University School of Public Health.
Melissa B. Weimer, DO, MCR
Melissa Weimer is board certified in general internal medicine and addiction medicine. She became the Medical Director of the Yale Addiction Medicine Consult Service and Assistant Professor of Medicine at Yale School of Medicine in 2018. Prior to serving in this role she worked as the Chief of Behavioral Health and Addiction Medicine at St. Peter’s Health Partners in Albany, NY and as Assistant Professor of Medicine in the Division of Internal Medicine at Oregon Health & Science University in Portland, OR. Dr. Weimer’s career has focused on treating patients who struggle with concomitant chronic pain and substance use disorders, expanding access and expertise around medication treatments for substance use disorders, and creating access to substance use disorder care for hospitalized patients. Dr. Weimer is an experienced educator in helping providers understand substance use disorders, how to address concomitant pain and substance use disorder, and how to safely and effectively prescribe opioids in the outpatient and inpatient setting.